These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1804672)

  • 21. Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma.
    Hohlfeld JM; Schmiedl A; Erpenbeck VJ; Venge P; Krug N
    J Allergy Clin Immunol; 2004 Mar; 113(3):496-502. PubMed ID: 15007353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide.
    Ballard PL; Gonzales LW; Godinez RI; Godinez MH; Savani RC; McCurnin DC; Gibson LL; Yoder BA; Kerecman JD; Grubb PH; Shaul PW
    Pediatr Res; 2006 Jan; 59(1):157-62. PubMed ID: 16326985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental model of respiratory distress syndrome by lung lavage with fluorocarbon].
    Takeda T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1417-22. PubMed ID: 2584820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of neonatal lung injury induced by monoclonal antibody to surfactant protein B.
    Grossmann G; Suzuki Y; Robertson B; Kobayashi T; Berggren P; Li WZ; Song GW; Sun B
    J Appl Physiol (1985); 1997 Jun; 82(6):2003-10. PubMed ID: 9173970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of transferrin saturated with iron with lung surfactant in respiratory failure.
    Hallman M; Sarnesto A; Bry K
    J Appl Physiol (1985); 1994 Aug; 77(2):757-66. PubMed ID: 8002525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay.
    Kuroki Y; Fukada Y; Takahashi H; Akino T
    Biochim Biophys Acta; 1985 Sep; 836(2):201-9. PubMed ID: 3839686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactant in pulmonary oxygen toxicity.
    Armbruster S; Klein J; Stouten EM; Erdmann W; Lachmann B
    Adv Exp Med Biol; 1987; 215():345-9. PubMed ID: 3673735
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigenicity of low molecular weight surfactant species.
    Strayer DS; Merritt TA; Makunike C; Hallman M
    Am J Pathol; 1989 Apr; 134(4):723-32. PubMed ID: 2705504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium interactions in pulmonary surfactant.
    Weber MJ; Possmayer F
    Biochim Biophys Acta; 1984 Oct; 796(1):83-91. PubMed ID: 6435680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary damage induced in mice by a monoclonal antibody to proteins associated with pig pulmonary surfactant.
    Fujita Y; Kogishi K; Suzuki Y
    Exp Lung Res; 1988; 14(2):247-60. PubMed ID: 3371277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory failure in mice caused by a hybridoma making antibodies to the 15 kDa surfactant apoprotein.
    Suzuki Y; Robertson B; Fujita Y; Grossmann G
    Acta Anaesthesiol Scand; 1988 May; 32(4):283-9. PubMed ID: 3394479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of alveolar surfactant aggregates in vitro and in vivo.
    Brackenbury AM; Malloy JL; McCaig LA; Yao LJ; Veldhuizen RA; Lewis JF
    Eur Respir J; 2002 Jan; 19(1):41-6. PubMed ID: 11852893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different surfactant treatment strategies for respiratory failure induced by hydrochloric acid aspiration in rats.
    Eijking EP; Gommers D; Kullander J; de Buijzer E; Beukenholdt RW; Lachmann B
    Adv Exp Med Biol; 1992; 317():349-55. PubMed ID: 1288143
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary surfactant and respiratory infections.
    Bisetti A
    Respiration; 1989; 55 Suppl 1():45-8. PubMed ID: 2682868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of the surfactant system of the mature lung.
    Spragg RG; Smith RM
    Am J Respir Crit Care Med; 1997 Feb; 155(2):756-60. PubMed ID: 9032225
    [No Abstract]   [Full Text] [Related]  

  • 37. High-throughput screening of respiratory hazards: Exploring lung surfactant inhibition with 20 benchmark chemicals.
    Liu JY; George IC; Hussain S; Sayes CM
    Toxicology; 2024 May; 504():153785. PubMed ID: 38518839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Scentilleography of the pulmonary tensive active Iodine-131 in humans].
    Skromne G; Celis González C; Ferez A
    Arch Inst Cardiol Mex; 1977; 47(3):294-6. PubMed ID: 579082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant: The importance of documented policy and procedure.
    Valotaire R
    Can J Respir Ther; 2014; 50(3):77. PubMed ID: 26078615
    [No Abstract]   [Full Text] [Related]  

  • 40. The development of selected reaction monitoring methods for targeted proteomics via empirical refinement.
    Bereman MS; MacLean B; Tomazela DM; Liebler DC; MacCoss MJ
    Proteomics; 2012 Apr; 12(8):1134-41. PubMed ID: 22577014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.